Bull Horn Holdings Corp., a special purpose acquisition company (SPAC), merged with Coeptis Therapeutics, inc., a publicly traded biopharmaceutical company developing cell therapy platforms for cancer, in October 2022. In January 2023, TKB Critical Technologies 1, a SPAC focused on investing in critical technologies, announced a merger with an already public company, Wejo, which had gone public via an earlier merger with another SPAC.
Source: SPAC Mergers with Public Companies: A New Trend?